(Q39262694)

10 September 2017

title

YB-1 suppression induces STAT3 proteolysis and sensitizes renal cancer to interferon-α. (English)

1 reference

10 September 2017

1 reference

1

Ario Takeuchi

1 reference

10 September 2017

Masaki Shiota

2

1 reference

10 September 2017

Katsunori Tatsugami

3

1 reference

10 September 2017

Akira Yokomizo

4

1 reference

10 September 2017

Kentaro Kuroiwa

5

1 reference

10 September 2017

Takashi Dejima

6

1 reference

10 September 2017

Shingo Tanaka

7

1 reference

10 September 2017

Momoe Itsumi

8

1 reference

10 September 2017

Masatoshi Eto

9

1 reference

10 September 2017

Seiji Naito

10

1 reference

10 September 2017

publication date

30 September 2012

1 reference

Cancer Immunology, Immunotherapy

10 September 2017

published in

1 reference

10 September 2017

volume

62

1 reference

10 September 2017

issue

3

1 reference

10 September 2017

page(s)

517-527

1 reference

Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma.

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

STATs and gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

STAT family of transcription factors in cytokine-mediated biological responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

The STATs of cancer--new molecular targets come of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

Stat proteins and oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-alpha 2b treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

YB-1 is important for an early stage embryonic development: neural tube formation and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

YB-1 is important for late-stage embryonic development, optimal cellular stress responses, and the prevention of premature senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

The pleiotropic functions of the Y-box-binding protein, YB-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

Mechanism of Synergistic Antitumor Effect of Sorafenib and Interferon-α on Treatment of Renal Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

Castration resistance of prostate cancer cells caused by castration-induced oxidative stress through Twist1 and androgen receptor overexpression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

A reduction of recipient regulatory T cells by cyclophosphamide contributes to an anti-tumor effect of nonmyeloablative allogeneic stem cell transplantation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

Stat3 as a potential target for cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

Combination Therapy of Bortezomib with Novel Targeted Agents: An Emerging Treatment Strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

STAT3 ser727 phosphorylation and its association with negative estrogen receptor status in breast infiltrating ductal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

ErbB-2 kinase is required for constitutive stat 3 activation in malignant human lung epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

YB-1, the E2F pathway, and regulation of tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

Regulatory T cells: history and perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1356-8

10.1007/S00262-012-1356-8

21 January 2018

Identifiers

DOI

1 reference

release_2v3ogjv2ujduldc7n2lr5yuxc4

10 September 2017

Fatcat ID

0 references

1 reference